- Shigeru KandaHead, Department of Experimental and Clinical Laboratory Medicine, 41-6 Sakuragi, Nagasaki 850-8523Interests: 168 publications, 9 grants, Editor of Frontiers in Bioscience, Oncology Letters
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.
- FES/FER kinase signaling in hematopoietic cells and leukemiasAndrew W.B. CraigFront. Biosci. (Landmark Ed) 2012, 17(3), 861–875; https://doi.org/10.2741/396158Download29Citations114Views
- Structure and regulation of the c-Fes protein-tyrosine kinaseSabine Hellwig, Thomas E. SmithgallFront. Biosci. (Landmark Ed) 2011, 16(8), 3146–3155; https://doi.org/10.2741/390219Download5Citations26Views
- The c-Fes protein tyrosine kinase as a potential anti-angiogenic target in cancerShigeru Kanda, Yasuyoshi MiyataFront. Biosci. (Landmark Ed) 2011, 16(3), 1024–1035; https://doi.org/10.2741/37329Download5Citations10Views